Bristol-Myers Squibb

Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bloomberg
Thu, 01/19/12 - 10:38 am
AstraZeneca
FDA
Bristol-Myers Squibb
diabetes
Dapagliflozin
Bristol-Myers’s Hepatitis C Pills Clear Virus Without Interferon in Study
Bloomberg
Wed, 01/18/12 - 05:57 pm
Bristol-Myers Squibb
hepatitis C
interferon
2 Large Cap Pharma Stocks To Look Into, 2 To Avoid
Seeking Alpha
Wed, 01/18/12 - 03:33 pm
Pfizer
Merck
Eli Lilly
Bristol-Myers Squibb
Second confirmed bidder for Inhibitex bodes well for Idenix, says Wedbush
Yahoo/Fly on the Wall
Wed, 01/18/12 - 10:22 am
M&A
Bristol-Myers Squibb
Inhibitex
Inhibitex Auction Shows Battle for Hepatitis Drugs
Minyanville
Wed, 01/18/12 - 09:49 am
hepatitis
hepatitis C
Inhibitex
Bristol-Myers Squibb
Why Big Pharma Doesn't Really Need (Or Even Want) A Pipeline
Seeking Alpha
Tue, 01/17/12 - 06:48 pm
Adolor
Alexion
Amgen
Cubist Pharmaceuticals
AstraZeneca
Bristol-Myers Squibb
Inhibitex
Merck
Pfizer
Stryker
The Best Big Pharma Dividend
Motley Fool
Sat, 01/14/12 - 11:53 am
Eli Lilly
Merck
Bristol-Myers Squibb
Bristol-Myers Raised Inhibitex Offer 30%
Bloomberg
Sat, 01/14/12 - 11:40 am
Bristol-Myers Squibb
Inhibitex
M&A
CEO Gaffe of the Week: Bristol-Myers Squibb
Motley Fool
Sat, 01/14/12 - 11:35 am
Bristol-Myers Squibb
Inhibitex
M&A
Analyzing 5 Biotech Stocks And Their Takeover Potential
Seeking Alpha
Fri, 01/13/12 - 10:33 am
Abbott Laboratories
Achillion
Alexion
Bristol-Myers Squibb
Gilead
GSK
Human Genome Sciences
Indenix
Inhibitex
JNJ
Pfizer
Vertex
Pharmasset
Bristol-Myers Squibb Begins Tender Offer to Acquire Inhibitex, Inc.
Yahoo
Fri, 01/13/12 - 09:27 am
Inhibitex
tender offer
M&A
Bristol-Myers Squibb
Inhibitex Shareholders Sue Over Bristol’s $2.5 Billion Offer
Bloomberg
Thu, 01/12/12 - 10:07 pm
shareholders
M&A
Inhibitex
Bristol-Myers Squibb
Bristol-Myers Squibb: Well Defined Strategy Catalyst For Success
Seeking Alpha
Thu, 01/12/12 - 09:08 am
Bristol-Myers Squibb
$3B or less is Big Pharma's M&A sweet spot
Fierce Pharma
Wed, 01/11/12 - 12:58 pm
M&A
Roche
Sanofi
Bristol-Myers Squibb
Novartis
Pfizer
Merck
Celldex Therapeutics: A Potential Triple With Data On The Way
Seeking Alpha
Wed, 01/11/12 - 10:58 am
Celldex
Amgen
Bristol-Myers Squibb
Dendreon
Seattle Genetics
Exelixis
Bristol CEO sees fruits of company transformation
Yahoo/AP
Tue, 01/10/12 - 05:05 pm
Pharma CEOs
Bristol-Myers Squibb
Lamberto Andreotti
3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
A White Hot Hep C Market: What The Wags Say
Pharmalot
Mon, 01/9/12 - 01:24 pm
hepatitis C
Inhibitex
Bristol-Myers Squibb
Gilead
Pharmasset
M&A
JPM kicks off with fevered focus on the next big biotech deal
Fierce Biotech
Mon, 01/9/12 - 10:42 am
JPMorgan
biotech
M&A
Inhibitex
Bristol-Myers Squibb
2 ETFs To Play A Surge In Biotech/Pharma M&A
Seeking Alpha
Mon, 01/9/12 - 10:39 am
Abbott Laboratories
Amgen
Biogen Idec
Gilead
Celgene
Bristol-Myers Squibb
JNJ
Eli Lilly
Merck
Pfizer
ETFs

Pages